Multicenter Analysis of Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment Regimen

Nirav N. Shah, Aniko Szabo, Raya Saba, Lauren Strelec, Dheeraj Kodali, John L. Vaughn, Olukemi Esan, David T. Yang, Anthony R. Mato, Abraham S. Kanate, Horatiu Olteanu, Mehdi Hamadani, Timothy S. Fenske, Vaishalee P. Kenkre, Jakub Svoboda, Amanda F. Cashen, Narendranath Epperla

Research output: Contribution to journalArticle

Abstract

Grade 3A follicular lymphoma (FL) is a heterogenous disease with multiple frontline treatment regimens. We performed a multicenter retrospective analysis to evaluate the efficacy of various frontline regimens for grade 3A FL. Although anthracycline-based therapy was superior to the combination of chemotherapy with cyclophosphamide, vincristine, and prednisone for grade 3A FL, clinical outcomes, including survival, were similar compared to bendamustine-based treatment.

Original languageEnglish (US)
Pages (from-to)95-102
Number of pages8
JournalClinical Lymphoma, Myeloma and Leukemia
Volume19
Issue number2
DOIs
StatePublished - Feb 1 2019
Externally publishedYes

Fingerprint

Follicular Lymphoma
Anthracyclines
Vincristine
Prednisone
Combination Drug Therapy
Cyclophosphamide
Therapeutics

Keywords

  • Chemotherapy
  • Non-Hodgkin lymphoma

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Multicenter Analysis of Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment Regimen. / Shah, Nirav N.; Szabo, Aniko; Saba, Raya; Strelec, Lauren; Kodali, Dheeraj; Vaughn, John L.; Esan, Olukemi; Yang, David T.; Mato, Anthony R.; Kanate, Abraham S.; Olteanu, Horatiu; Hamadani, Mehdi; Fenske, Timothy S.; Kenkre, Vaishalee P.; Svoboda, Jakub; Cashen, Amanda F.; Epperla, Narendranath.

In: Clinical Lymphoma, Myeloma and Leukemia, Vol. 19, No. 2, 01.02.2019, p. 95-102.

Research output: Contribution to journalArticle

Shah, NN, Szabo, A, Saba, R, Strelec, L, Kodali, D, Vaughn, JL, Esan, O, Yang, DT, Mato, AR, Kanate, AS, Olteanu, H, Hamadani, M, Fenske, TS, Kenkre, VP, Svoboda, J, Cashen, AF & Epperla, N 2019, 'Multicenter Analysis of Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment Regimen', Clinical Lymphoma, Myeloma and Leukemia, vol. 19, no. 2, pp. 95-102. https://doi.org/10.1016/j.clml.2018.11.010
Shah, Nirav N. ; Szabo, Aniko ; Saba, Raya ; Strelec, Lauren ; Kodali, Dheeraj ; Vaughn, John L. ; Esan, Olukemi ; Yang, David T. ; Mato, Anthony R. ; Kanate, Abraham S. ; Olteanu, Horatiu ; Hamadani, Mehdi ; Fenske, Timothy S. ; Kenkre, Vaishalee P. ; Svoboda, Jakub ; Cashen, Amanda F. ; Epperla, Narendranath. / Multicenter Analysis of Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment Regimen. In: Clinical Lymphoma, Myeloma and Leukemia. 2019 ; Vol. 19, No. 2. pp. 95-102.
@article{5b004f5c5b924fa58b3432f1a972d918,
title = "Multicenter Analysis of Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment Regimen",
abstract = "Grade 3A follicular lymphoma (FL) is a heterogenous disease with multiple frontline treatment regimens. We performed a multicenter retrospective analysis to evaluate the efficacy of various frontline regimens for grade 3A FL. Although anthracycline-based therapy was superior to the combination of chemotherapy with cyclophosphamide, vincristine, and prednisone for grade 3A FL, clinical outcomes, including survival, were similar compared to bendamustine-based treatment.",
keywords = "Chemotherapy, Non-Hodgkin lymphoma",
author = "Shah, {Nirav N.} and Aniko Szabo and Raya Saba and Lauren Strelec and Dheeraj Kodali and Vaughn, {John L.} and Olukemi Esan and Yang, {David T.} and Mato, {Anthony R.} and Kanate, {Abraham S.} and Horatiu Olteanu and Mehdi Hamadani and Fenske, {Timothy S.} and Kenkre, {Vaishalee P.} and Jakub Svoboda and Cashen, {Amanda F.} and Narendranath Epperla",
year = "2019",
month = "2",
day = "1",
doi = "10.1016/j.clml.2018.11.010",
language = "English (US)",
volume = "19",
pages = "95--102",
journal = "Clinical Lymphoma, Myeloma and Leukemia",
issn = "2152-2669",
publisher = "Cancer Media Group",
number = "2",

}

TY - JOUR

T1 - Multicenter Analysis of Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment Regimen

AU - Shah, Nirav N.

AU - Szabo, Aniko

AU - Saba, Raya

AU - Strelec, Lauren

AU - Kodali, Dheeraj

AU - Vaughn, John L.

AU - Esan, Olukemi

AU - Yang, David T.

AU - Mato, Anthony R.

AU - Kanate, Abraham S.

AU - Olteanu, Horatiu

AU - Hamadani, Mehdi

AU - Fenske, Timothy S.

AU - Kenkre, Vaishalee P.

AU - Svoboda, Jakub

AU - Cashen, Amanda F.

AU - Epperla, Narendranath

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Grade 3A follicular lymphoma (FL) is a heterogenous disease with multiple frontline treatment regimens. We performed a multicenter retrospective analysis to evaluate the efficacy of various frontline regimens for grade 3A FL. Although anthracycline-based therapy was superior to the combination of chemotherapy with cyclophosphamide, vincristine, and prednisone for grade 3A FL, clinical outcomes, including survival, were similar compared to bendamustine-based treatment.

AB - Grade 3A follicular lymphoma (FL) is a heterogenous disease with multiple frontline treatment regimens. We performed a multicenter retrospective analysis to evaluate the efficacy of various frontline regimens for grade 3A FL. Although anthracycline-based therapy was superior to the combination of chemotherapy with cyclophosphamide, vincristine, and prednisone for grade 3A FL, clinical outcomes, including survival, were similar compared to bendamustine-based treatment.

KW - Chemotherapy

KW - Non-Hodgkin lymphoma

UR - http://www.scopus.com/inward/record.url?scp=85058679508&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058679508&partnerID=8YFLogxK

U2 - 10.1016/j.clml.2018.11.010

DO - 10.1016/j.clml.2018.11.010

M3 - Article

C2 - 30581160

AN - SCOPUS:85058679508

VL - 19

SP - 95

EP - 102

JO - Clinical Lymphoma, Myeloma and Leukemia

JF - Clinical Lymphoma, Myeloma and Leukemia

SN - 2152-2669

IS - 2

ER -